1. Home
  2. PBMWW vs NOW Comparison

PBMWW vs NOW Comparison

Compare PBMWW & NOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBMWW
  • NOW
  • Stock Information
  • Founded
  • PBMWW N/A
  • NOW 2004
  • Country
  • PBMWW Canada
  • NOW United States
  • Employees
  • PBMWW 10
  • NOW N/A
  • Industry
  • PBMWW
  • NOW Computer Software: Prepackaged Software
  • Sector
  • PBMWW
  • NOW Technology
  • Exchange
  • PBMWW Nasdaq
  • NOW Nasdaq
  • Market Cap
  • PBMWW N/A
  • NOW N/A
  • IPO Year
  • PBMWW N/A
  • NOW 2012
  • Fundamental
  • Price
  • PBMWW $0.01
  • NOW $1,011.84
  • Analyst Decision
  • PBMWW
  • NOW Buy
  • Analyst Count
  • PBMWW 0
  • NOW 28
  • Target Price
  • PBMWW N/A
  • NOW $966.93
  • AVG Volume (30 Days)
  • PBMWW N/A
  • NOW 1.4M
  • Earning Date
  • PBMWW N/A
  • NOW 10-23-2024
  • Dividend Yield
  • PBMWW N/A
  • NOW N/A
  • EPS Growth
  • PBMWW N/A
  • NOW N/A
  • EPS
  • PBMWW N/A
  • NOW 6.43
  • Revenue
  • PBMWW N/A
  • NOW $10,464,000,000.00
  • Revenue This Year
  • PBMWW N/A
  • NOW $23.59
  • Revenue Next Year
  • PBMWW N/A
  • NOW $20.51
  • P/E Ratio
  • PBMWW N/A
  • NOW $157.38
  • Revenue Growth
  • PBMWW N/A
  • NOW 23.48
  • 52 Week Low
  • PBMWW N/A
  • NOW $637.99
  • 52 Week High
  • PBMWW N/A
  • NOW $1,061.66
  • Technical
  • Relative Strength Index (RSI)
  • PBMWW N/A
  • NOW 61.37
  • Support Level
  • PBMWW N/A
  • NOW $928.35
  • Resistance Level
  • PBMWW N/A
  • NOW $1,061.66
  • Average True Range (ATR)
  • PBMWW 0.00
  • NOW 20.76
  • MACD
  • PBMWW 0.00
  • NOW 4.53
  • Stochastic Oscillator
  • PBMWW 0.00
  • NOW 62.63

About PBMWW Psyence Biomedical Ltd. Warrant

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Share on Social Networks: